MaximYankelevichMD
Pediatric Hematology & Oncology • Philadelphia, PAPediatric Neuro-Oncology
St. Christopher's Hospital for Children
Dr. Yankelevich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
160 E Erie Ave
Philadelphia, PA 19134Phone+1 215-427-5348
Education & Training
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2003 - 2006
Children's Hospital of MichiganResidency, Pediatrics, 2000 - 2003
Omsk State Medical AcademyClass of 1992
Certifications & Licensure
MI State Medical License 2000 - 2025
NJ State Medical License 2019 - 2025
PA State Medical License 2023 - 2024- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
- Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
- Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer Start of enrollment: 2013 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 36 citationsChoroid plexus carcinoma in children: the Head Start experience.Wafik Zaky, Girish Dhall, Soumen Khatua, Robert J. Brown, Kevin Ginn
Pediatric Blood & Cancer. 2015-05-01 - 7 citationsMolecular insights into malignant progression of atypical choroid plexus papillomaMaxim Yankelevich, Jonathan L. Finlay, Hamza S. Gorsi, William J. Kupsky, Daniel R. Boue
Cold Spring Harbor Molecular Case Studies. 2021-02-19 - 88 citationsOncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.Farshad Nassiri, Vikas Patil, Leeor S Yefet, Olivia Singh, Jeff Liu
Nature Medicine. 2023-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
